Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist — 2020 Animal Study - | BudProfiles

Home

Studies

Arachidonyl-2'-chloroethylamide (ACEA), a syntheti...

PositiveAnimal Study -2020

Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB 1 R gene expression and reduces dyskinesias in a rat model of Parkinson's disease

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Parkinson's

Related Studies

Positive

Low doses of cannabis extract ameliorate non-motor symptoms of Parkinson’s disease patients: a case series

2025·Review/Other

Positive

Orexinergic and cannabinoid CB1 receptors interaction on genetic absence epilepsy in WAG/Rij rats

2025·Animal Study -

Inconclusive

The Effect of the Eight Week of High-intensity Interval Training and Bee Pollen Consumption on Pain Tolerance and Type 1 Cannabinoid Receptors in Rats Exposed to Cadmium

2025·Animal Study -

Positive

Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism

2025·Review/Other

Positive

Therapeutic Potential and Challenges of <i>Cannabis sativa</i> in Neurological Disorders: Pathways to Integration into Health Systems

2025·Review/Other

Inconclusive

O uso da Cannabis no tratamento da Doença de Parkinson: sintomas motores e não-motores

2025·Review/Other

Cannabinoids

Synthetic Cannabinoid (unspecified)

Organ Systems

Nervous System

Study Details

Type: Animal Study -
Year: 2020
Study ID: #2020577